首页> 美国卫生研究院文献>BMC Cancer >Erratum to: Suberoylanilide hydroxamic acid an inhibitor of histone deacetylase suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells

【2h】

Erratum to: Suberoylanilide hydroxamic acid an inhibitor of histone deacetylase suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells

机译：勘误到：磺酰苯胺异羟肟酸组蛋白脱乙酰基酶的抑制剂抑制高度侵袭性胰腺癌PaTu8988细胞的血管生成模拟和增殖

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 BMC Cancer
作者
Xing-dong Xu; Lan Yang; Li-yun Zheng; Yan-yan Pan; Zhi-fei Cao; Zhi-qing Zhang; Quan-sheng Zhou; Bo Yang; Cong Cao;
展开▼
作者单位

展开▼
年(卷),期 2016(16),-1
年度 2016
页码 374
总页数 1
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells [J] . Aparna Maiti, Qianya Qi, Xuan Peng, International journal of oncology . 2019,第1期

机译：I类组蛋白脱乙酰基酶抑制剂通过增强侵袭性人TNBC细胞中肿瘤抑制因子和抗血管生成基因的表达来抑制血管生成拟态
2. Histone deacetylase inhibitor suberoyl bis-hydroxamic acid suppresses cell proliferation and induces apoptosis in breast cancer cells [J] . Yang Xinmiao, Zhang Ning, Shi Zeliang, Molecular medicine reports . 2015,第4期

机译：组蛋白脱乙酰基酶抑制剂亚磺酰双异羟肟酸抑制乳腺癌细胞的增殖并诱导其凋亡
3. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells [J] . Ahrum Min, Seock-Ah Im, Debora Keunyoung Kim, Breast Cancer Research . 2015,第1期

机译：组蛋白脱乙酰基酶抑制剂，亚磺酰苯胺异羟肟酸（SAHA），增强三阴性乳腺癌细胞中聚（ADP-核糖）聚合酶（PARP）抑制剂olaparib的抗肿瘤作用
4. In silico modification of Zn~(2+) binding group of suberoylanilide hydroxamic acid (SAHA) by organoselenium compounds as Homo sapiens class II HDAC inhibitor of cervical cancer [C] . Usman Sumo Friend Tambunan, Ridla Bakri, Arli Aditya Parikesit Joint Conference on Chemisty . 2016

机译：通过有机烯化合物作为Zn〜（2+）结合基团的Zn〜（2+）结合基团的Zn〜（2+）结合基团的组织化合物作为宫颈癌的HOMO SAPIENS II HDAC抑制剂
5. The structural requirements of histone deacetylase (HDAC) inhibitors: Suberoylanilide hydroxamic acid (SAHA) analogues modified at C3, C6, and C7 positions enhance selectivity [D] . Choi, Sun Ea 2012

机译：组蛋白脱乙酰基酶（HDAC）抑制剂的结构要求：在C3，C6和C7位置修饰的Suberoylanilide异羟肟酸（SAHA）类似物可提高选择性
6. Suberoylanilide hydroxamic acid an inhibitor of histone deacetylase suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells [O] . Xing-dong Xu, Lan Yang, Li-yun Zheng, 2014

机译：Suberoylanilide异羟肟酸组蛋白脱乙酰基酶的抑制剂抑制高度侵袭性胰腺癌PaTu8988细胞的血管生成模拟和增殖
7. Erratum to: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells [O] . 2016

机译：勘误到：磺酰苯胺异羟肟酸，组蛋白脱乙酰基酶的抑制剂，抑制高度侵袭性胰腺癌PaTu8988细胞的血管生成模拟和增殖

Erratum to: Suberoylanilide hydroxamic acid an inhibitor of histone deacetylase suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells

著录项

相似文献

相关主题

期刊订阅